DexCom (DXCM) PT Lowered to $398 at Morgan Stanley
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $88.76 -1.1%
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Morgan Stanley analyst David Lewis lowered the price target on DexCom (NASDAQ: DXCM) to $398.00 (from $428.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
- JD Health International Inc (6618:HK) PT Lowered to HK$60 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
